Aura Biosciences shareholders elect David Johnson and Karan Takhar as directors, ratify EY auditor

Aura Biosciences, Inc.

At the annual meeting on June 7, 2023, shareholders elected David Johnson and Karan Takhar as Class II directors until 2026, with over 13.2 million votes for each.
The appointment of Ernst & Young as independent auditor for fiscal year 2023 was ratified with 25,725,525 votes for, 3,721 against, and 1,826 abstentions.
Broker non-votes on director elections totaled 9,206,963; there were no broker non-votes on auditor ratification.
Total shares present or represented were 25,731,072 out of 37,800,102 entitled to vote.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aura Biosciences, Inc. shareholders approved Ratification of Appointment of Independent Registered Accounting Firm at the 2023-06-07 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 2 - Ratification of Appointment of Independent Registered Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2023. Votes For Votes Against Abstentions 25,725,525 3,721 1,826 There were zero broker non-votes regarding this proposal.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Aura Biosciences, Inc. shareholders approved Election of Directors at the 2023-06-07 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 1 - Election of Directors The Company’s stockholders elected the two (2) director nominees below to the Company’s Board of Directors as Class II directors to hold office until the 2026 Annual Meeting of Stockholders of the Company or until their successors are duly elected and qualified. Director Nominee Votes For Votes Withheld Broker Non-Votes David Johnson 13,248,297 3,275,812 9,206,963 Karan Takhar 13,248,607 3,275,502 9,206,963

View on SEC.gov

640 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Aura Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-162617

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.